> ## Content Index
> Fetch the complete content index at: https://med-techinsights.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# SHL Medical opens new $220m facility to serve growing autoinjector market
- URL: https://med-techinsights.com/shl-medical-opens-new-220m-facility-to-serve-growing-autoinjector-market/
- Published: 2025-04-01T09:10:49.000Z
- Updated: 2026-10-23T02:36:51.000Z
- Description: SHL Medical, a global leader in the design, development, andmanufacturing of advanced autoinjector solutions, has officiallyinaugurated its new state-of-the-art manufacturing facility in NorthCharleston, South Carolina. This strategic expansion marks a significant milestone in the Swiss-based compan
- Author: Oliver Johnson
- Tags: Medical Device Manufacturing, News

[**SHL Medical**](https://www.shl-medical.com/?ref=med-techinsights.com), a global leader in the design, development, and  
manufacturing of advanced autoinjector solutions, has officially  
inaugurated its new state-of-the-art manufacturing facility in North  
Charleston, South Carolina.

This strategic expansion marks a significant milestone in the Swiss-based company’s global growth,  
reinforcing its commitment to meeting the increasing worldwide demand  
for autoinjectors, most notably used in the cardiometabolic sector.

The new facility will manufacture SHL Medical’s industry-leading  
autoinjectors, which are used in some of the world’s best-selling  
medications in areas such as endocrine and metabolic disorders  
(including GLP-1 therapies), dermatology, musculoskeletal diseases,  
and other therapy areas. It ensures a reliable supply of these  
critical devices to millions of patients worldwide.

SHL Medical is significantly increasing its production capacity to  
meet growing demand in North America while strengthening supply chain  
resilience.

“US-based production is a major step forward in our  
global expansion and reinforces our position as the leader in  
providing end-to-end drug delivery solutions,” said Ulrich Faessler,  
CEO & Chairman of SHL Medical. “With our established site in Taiwan  
and the upcoming facility in Switzerland, we will be the only  
autoinjector manufacturer operating across three continents, bringing us even closer to our customers.”

The fully automatised 360,000 ft facility represents a 220 million USD  
investment and has already created over 300 local jobs, contributing  
to the economic growth of the region.

Equipped with cutting-edge  
medical device injection moulding technology and fully automated  
assembly capabilities, the site ensures unmatched precision,  
efficiency, and quality in SHL Medical’s advanced drug delivery  
solutions.

By leveraging its existing final assembly, labeling, and packaging  
operations in Deerfield Beach, Florida, and integrating recent  
acquisitions under SHL Advantec, the North Charleston facility  
enhances SHL Medical’s US presence and solidifies its leadership in  
large-scale autoinjector production. The company is on track to  
deliver 1.5 billion devices to customers in 2025.

“The most trusted autoinjector brand is now made in the USA. We are  
proud to be contributing to the growth of the local economy and  
becoming a key player in the area while contributing to our  
sustainability goals.” adds Kimberlee Steele, Managing Director North  
America at SHL Medical.

The Grand Opening event, attended by approximately 180 guests,  
including South Carolina’s Governor Henry McMaster and Swiss Embassy  
Consul General Urs Broennimann, marked the official opening of SHL  
Medical’s innovative autoinjector production in the United States.